Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients

[1]  C. Deutschman,et al.  Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes , 2020, The Lancet Respiratory Medicine.

[2]  Keith Sigel,et al.  An inflammatory cytokine signature predicts COVID-19 severity and survival , 2020, Nature Medicine.

[3]  O. Cabrera-Marante,et al.  IL-6–based mortality risk model for hospitalized patients with COVID-19 , 2020, Journal of Allergy and Clinical Immunology.

[4]  S. Baldovino,et al.  Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in severe patients with COVID-19. , 2020, Clinical and experimental rheumatology.

[5]  S. Baldovino,et al.  Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. , 2020 .

[6]  R. Assaly,et al.  Elevated interleukin‐6 and severe COVID‐19: A meta‐analysis , 2020, Journal of medical virology.

[7]  Nils Kucher,et al.  Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy , 2020, Thrombosis Research.

[8]  S. Alzghari,et al.  Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review , 2020, Journal of Clinical Virology.

[9]  M. Netea,et al.  Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure , 2020, Cell Host & Microbe.

[10]  S. Merler,et al.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.

[11]  Taojiao Wang,et al.  Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.

[12]  J. Low,et al.  Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. , 2020, JAMA.

[13]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[14]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[15]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[16]  J. Luyendyk,et al.  The multifaceted role of fibrinogen in tissue injury and inflammation. , 2019, Blood.

[17]  J. Ashworth,et al.  Role of C-Reactive Protein at Sites of Inflammation and Infection , 2018, Front. Immunol..

[18]  R. Bellomo,et al.  Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup , 2017, Nature Reviews Nephrology.

[19]  Chuan Qin,et al.  Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways , 2015, The Journal of infectious diseases.

[20]  R. Baric,et al.  Rapid generation of a mouse model for Middle East respiratory syndrome , 2014, Proceedings of the National Academy of Sciences.

[21]  A. Osterhaus,et al.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.

[22]  Dohyeon Yu,et al.  Kinetics of IL-6 and TNF-α changes in a canine model of sepsis induced by endotoxin. , 2012, Veterinary immunology and immunopathology.

[23]  Christopher D. Paddock,et al.  Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection , 2009, Journal of Virology.

[24]  D. Dwyer,et al.  Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets , 2005, International Journal of Infectious Diseases.

[25]  E. Yeh,et al.  Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells , 2003, Circulation.

[26]  J. Dorca,et al.  Molecular Inflammatory Responses Measured in Blood of Patients with Severe Community-Acquired Pneumonia , 2003, Clinical Diagnostic Laboratory Immunology.

[27]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[28]  I. al Hifzi,et al.  Isolated cerebrospinal fluid eosinophilia due to Streptococcus bovis meningitis in an infant. , 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[29]  C. Sprung,et al.  The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study , 1999, Intensive Care Medicine.

[30]  U. Rüther,et al.  Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. , 1997, The Biochemical journal.

[31]  J. Kavanagh,et al.  Kinetics of circulating TNF-alpha and TNF soluble receptors following surgery in a clinical model of sepsis. , 1996, Cytokine.

[32]  S. Opal,et al.  Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. , 1996, The New England journal of medicine.

[33]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .

[34]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[35]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.